IL17A and synovial sarcoma: TH1, TH2, and/or TH17 cells are thought to then promote IL-17–, TNF-α–, and/or IL-1–dependent neutrophil recruitment, activation, and extracellular trap formation.1 Genetic variants may increase the risk of SS development independent of malignancy.